Sacral neuromodulation and cardiac pacemakers

Roth, Ted M.

doi:10.1007/s00192-009-1091-7

Cited by 14 publications

(16 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patients were monitored during the second stage and the first round of programming postoperatively. Additionally, Roth [6] reported 5 patients with cardiac pacemakers who underwent staged implants under local sedation. Intraoperative cardiac monitoring and postoperative telemetry did not demonstrate cross-interference with the test stimulation.…”

Section: Discussionmentioning

confidence: 99%

Sacral Neuromodulation in Patients With a Cardiac Pacemaker

Gahzi

Hassouna

2016

Int Neurourol J

View full text Add to dashboard Cite

The objective of this study was to describe our experience using sacral neuromodulation to treat urinary urgency, frequency, urge incontinence, and chronic urinary retention in patients with cardiac pacemakers. With the increasingly widespread use of InterStim for bladder function restoration, we are seeing more complex patients with multiple comorbidities, including cardiac conditions. Herein, we report 3 cases of individuals with cardiac pacemakers who underwent InterStim implantation to treat urinary conditions. This study is a case series of 3 patients with cardiac pacemakers who underwent sacral neuromodulation to treat refractory voiding dysfunction. The initial patient screening for InterStim therapy involved percutaneous nerve evaluation (PNE), in which a temporary untined lead wire was placed through the S3 foramen. Patients who did not respond to PNE proceeded to a staged implant. All patients in this study had a greater than 50% improvement of their urinary symptoms during the initial trial and underwent placement of the InterStim implantable pulse generator (IPG). Postoperative programming was done under electrocardiogram monitoring by a cardiologist. No interference was observed between the Inter-Stim IPG and the cardiac pacemaker. In this group of patients, sacral neuromodulation in the presence of a cardiac pacemaker appears to have been safe.

show abstract

Section: Discussionmentioning

confidence: 99%

Sacral Neuromodulation in Patients With a Cardiac Pacemaker

Gahzi

Hassouna

2016

Int Neurourol J

View full text Add to dashboard Cite

show abstract

“…Only SNM is currently FDA approved for treatment of bladder dysfunction. Roth [21] published a small case series showing that SNM could be used safely in conjunction with a cardiac pacemaker. A unique series of two patients with prior bladder augmentation and persistent symptoms by Rasmussen and colleagues [22] showed that SNM was an effective treatment after failed bladder augmentation.…”

Section: Literature Reviewmentioning

confidence: 98%

Sacral Nerve Modulation in Overactive Bladder

Occhino

Siegel

2010

Curr Urol Rep

View full text Add to dashboard Cite

show abstract

“…Others include coagulation disorders and local acute sacrum infection. SNM appears to be safe in the presence of a cardiac pacemaker without cardioversion/ defibrillation technology (Wallace et al, 2007) (Roth, 2010). Some conditions are considered challenging as MRI & pregnancy; however, more details are discussed upcoming in the chapter.…”

Section: Contraindicationsmentioning

confidence: 99%